The objective of this Recruitment and Assessment (R&A) Shared Resource for the CCNMD is to support all of the Center's projects. There are five main aims of R&A: 1) to continue to implement a well functioning screening, recruitment, and assessment process for CCNMD projects; 2) to recruit a minimum of 50 elderly patients meeting entry criteria for CCNMD projects; 3) to recruit and screen the normal, age-matched and young volunteers required for CCNMD projects; 4) to maintain a quality control system to monitor the work of the R&A staff for reliability; 5) to conduct standardized MRI studies for patients assessment, and 6) to create an autopsy component to obtain material for project 2. The R&A Shared Resource will meet these goals chiefly through highly trained key personnel and research staff. There will 0.75 FTE research psychiatrists, a 0.20 FTE neuropsychologist, 1.5 FTE research assistants, and a full-time neuropsychological technician. There will also be an autopsy component for which we have budgeted a half-time Autopsy Coordinator, 0.1 FTE Pathology Fellow, and 0.1 FTE Histology Technician. The staff will be supported by the Center's sophisticated data gathering and management system, which includes a computerized, real-time data entry format, scannable self-rating forms, and electronic submission of data to the Data Management Shared Resource. Subjects will receive a thorough psychiatric assessment, medical assessment, a detailed review of cardiovascular and cerebrovascular risk factors, standardized neurological examination, and a standardized cognitive assessment including a comprehensive neuropsychological test battery. Patients will be recruited through a variety of sources, including the inpatient service at Duke and a state hospital, Duke affiliated clinics, the Duke ECT services, clinical trials, and an NIMH-sponsored naturalistic longitudinal study of depression. Elderly controls will be obtained through an Aging Center Registry of elderly volunteers. The R&A staff will work to ensure that all subjects completed CCNMD protocols, R&A staff will find appropriate follow-up for depressed subjects, either through referral or enrollment in other research studies.
| Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739 |
| Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384 |
| Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738 |
| Mez, Jesse; Mukherjee, Shubhabrata; Thornton, Timothy et al. (2016) The executive prominent/memory prominent spectrum in Alzheimer's disease is highly heritable. Neurobiol Aging 41:115-121 |
| Ridge, Perry G; Hoyt, Kaitlyn B; Boehme, Kevin et al. (2016) Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging 41:200.e13-200.e20 |
| Hohman, Timothy J; Bush, William S; Jiang, Lan et al. (2016) Discovery of gene-gene interactions across multiple independent data sets of late onset Alzheimer disease from the Alzheimer Disease Genetics Consortium. Neurobiol Aging 38:141-150 |
| Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17 |
| Jacobsen, Jacob Pr; Rudder, Meghan L; Roberts, Wendy et al. (2016) SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept. Neuropsychopharmacology 41:2324-34 |
| Ebbert, Mark T W; Boehme, Kevin L; Wadsworth, Mark E et al. (2016) Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk. Alzheimers Dement 12:121-129 |
| Hohman, Timothy J; Cooke-Bailey, Jessica N; Reitz, Christiane et al. (2016) Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk. Alzheimers Dement 12:233-43 |
Showing the most recent 10 out of 250 publications
